{"id":"https://openalex.org/W1846464686","doi":"https://doi.org/10.1111/dom.12548","title":"Cardiovascular and heart failure safety profile of vildagliptin: a meta\u2010analysis of 17 000 patients","display_name":"Cardiovascular and heart failure safety profile of vildagliptin: a meta\u2010analysis of 17 000 patients","alternate_titles":[],"publication_year":2015,"publication_date":"2015-09-10","ids":{"openalex":"https://openalex.org/W1846464686","doi":"https://doi.org/10.1111/dom.12548","mag":"1846464686","pmid":"https://pubmed.ncbi.nlm.nih.gov/26250051"},"language":"en","primary_location":{"id":"doi:10.1111/dom.12548","doi":"https://doi.org/10.1111/dom.12548","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.12548","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1846464686"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111429189","display_name":"Gordon T. McInnes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"G. McInnes","raw_affiliation_strings":["Institute of Cardiovascular and Medical Sciences University of Glasgow Glasgow UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cardiovascular and Medical Sciences University of Glasgow Glasgow UK","institution_ids":["https://openalex.org/I7882870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053232051","display_name":"Marc Evans","orcid":"https://orcid.org/0000-0003-0671-0778","observed_orcids":["https://orcid.org/0000-0003-0671-0778"]},"institutions":[{"id":"https://openalex.org/I4210146878","display_name":"University Hospital Llandough","ror":"https://ror.org/05fcrn131","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1299209451","https://openalex.org/I4210144625","https://openalex.org/I4210146878"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Evans","raw_affiliation_strings":["University Hospital Llandough, Cardiff, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Llandough, Cardiff, UK","institution_ids":["https://openalex.org/I4210146878"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019711625","display_name":"Stefano Del Prato","orcid":"https://orcid.org/0000-0002-5388-0270","observed_orcids":["https://orcid.org/0000-0002-5388-0270","https://orcid.org/0000-0001-5905-0211"]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Del Prato","raw_affiliation_strings":["Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053898553","display_name":"Michael St\u00fcmvoll","orcid":"https://orcid.org/0000-0001-6225-8240","observed_orcids":["https://orcid.org/0000-0001-6225-8240","https://orcid.org/0000-0003-3054-1994"]},"institutions":[{"id":"https://openalex.org/I4210125843","display_name":"University Hospital Leipzig","ror":"https://ror.org/028hv5492","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210125843"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Stumvoll","raw_affiliation_strings":["Division of Endocrinology University Hospital Leipzig Leipzig Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology University Hospital Leipzig Leipzig Germany","institution_ids":["https://openalex.org/I4210125843"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007864342","display_name":"Anja Schweizer","orcid":"https://orcid.org/0000-0001-8787-3442","observed_orcids":["https://orcid.org/0000-0001-8787-3442"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Schweizer","raw_affiliation_strings":["Novartis Pharma AG, Basel, SWITZERLAND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, SWITZERLAND","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019524426","display_name":"Valentina Lukashevich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"V. Lukashevich","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation East Hanover, NJ USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation East Hanover, NJ USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Q. Shao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Q. Shao","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation East Hanover, NJ USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation East Hanover, NJ USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068333266","display_name":"Wolfgang Kothny","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W. Kothny","raw_affiliation_strings":["Novartis Pharma AG, Basel, SWITZERLAND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, SWITZERLAND","institution_ids":["https://openalex.org/I1283582996"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5111429189"],"corresponding_institution_ids":["https://openalex.org/I7882870"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":2.1314,"has_fulltext":false,"cited_by_count":117,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.89574091,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":100},"biblio":{"volume":"17","issue":"11","first_page":"1085","last_page":"1092"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vildagliptin","display_name":"vildagliptin","score":1.0},{"id":"https://openalex.org/keywords/cardiovascular-safety","display_name":"cardiovascular safety","score":0.9440000057220459},{"id":"https://openalex.org/keywords/risk-factors-for-heart-failure","display_name":"heart failure risk","score":0.8199999928474426},{"id":"https://openalex.org/keywords/major-adverse-cardiovascular-events","display_name":"major adverse cardiovascular events","score":0.9459999799728394},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9800000190734863},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.7710000276565552},{"id":"https://openalex.org/keywords/congestive-heart-failure","display_name":"congestive heart failure","score":0.7509999871253967},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.972000002861023},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.9700000286102295},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.9819999933242798},{"id":"https://openalex.org/keywords/cardiovascular-mortality","display_name":"cardiovascular mortality","score":0.8569999933242798},{"id":"https://openalex.org/keywords/heart-failure-hospitalization","display_name":"heart failure hospitalization","score":0.7419999837875366},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.37599998712539673},{"id":"https://openalex.org/keywords/high-risk-patients","display_name":"high-risk patients","score":0.5360000133514404},{"id":"https://openalex.org/keywords/relative-risk","display_name":"relative risk","score":0.34700000286102295},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.6000000238418579}],"concepts":[{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.979315996170044},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8556734323501587},{"id":"https://openalex.org/C2780739214","wikidata":"https://www.wikidata.org/wiki/Q6723023","display_name":"Mace","level":4,"score":0.6818753480911255},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6779128909111023},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.6049686074256897},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.5987881422042847},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5426937937736511},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.5363287925720215},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4784260392189026},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.47123655676841736},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.46802598237991333},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4676031172275543},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4545125961303711},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.41351646184921265},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4091998338699341},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.33784687519073486},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3188939094543457},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.14348351955413818},{"id":"https://openalex.org/C2780400711","wikidata":"https://www.wikidata.org/wiki/Q2008344","display_name":"Percutaneous coronary intervention","level":3,"score":0.08923667669296265},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077597","descriptor_name":"Vildagliptin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1111/dom.12548","doi":"https://doi.org/10.1111/dom.12548","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.12548","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:26250051","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26250051","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"},{"id":"pmh:oai:arpi.unipi.it:11568/763666","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11568/763666","pdf_url":null,"source":{"id":"https://openalex.org/S4377196265","display_name":"CINECA IRIS Institutial research information system (University of Pisa)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I108290504","host_organization_name":"University of Pisa","host_organization_lineage":["https://openalex.org/I108290504"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:arpi.unipi.it:11568/837839","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11568/837839","pdf_url":null,"source":{"id":"https://openalex.org/S4377196265","display_name":"CINECA IRIS Institutial research information system (University of Pisa)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I108290504","host_organization_name":"University of Pisa","host_organization_lineage":["https://openalex.org/I108290504"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320332932","display_name":"Merck Sharp and Dohme","ror":"https://ror.org/004nn4n27"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":63,"referenced_works":["https://openalex.org/W103558615","https://openalex.org/W172609984","https://openalex.org/W603325110","https://openalex.org/W1857972531","https://openalex.org/W1969389642","https://openalex.org/W1970406523","https://openalex.org/W1972565816","https://openalex.org/W1973383046","https://openalex.org/W1977619586","https://openalex.org/W1979982110","https://openalex.org/W1982067008","https://openalex.org/W1984588810","https://openalex.org/W1989976483","https://openalex.org/W1991951001","https://openalex.org/W2003221950","https://openalex.org/W2020638064","https://openalex.org/W2024567427","https://openalex.org/W2027249582","https://openalex.org/W2028317115","https://openalex.org/W2041445139","https://openalex.org/W2043326088","https://openalex.org/W2047353065","https://openalex.org/W2054599204","https://openalex.org/W2059241568","https://openalex.org/W2063362369","https://openalex.org/W2063489619","https://openalex.org/W2063976195","https://openalex.org/W2064130493","https://openalex.org/W2069397244","https://openalex.org/W2073379059","https://openalex.org/W2079787842","https://openalex.org/W2079841945","https://openalex.org/W2081947250","https://openalex.org/W2089443047","https://openalex.org/W2092920113","https://openalex.org/W2099677425","https://openalex.org/W2101293928","https://openalex.org/W2102279107","https://openalex.org/W2103828712","https://openalex.org/W2107562831","https://openalex.org/W2114528209","https://openalex.org/W2114587126","https://openalex.org/W2117762041","https://openalex.org/W2118619033","https://openalex.org/W2118830784","https://openalex.org/W2119114384","https://openalex.org/W2121242002","https://openalex.org/W2124465362","https://openalex.org/W2127125241","https://openalex.org/W2127854619","https://openalex.org/W2132600168","https://openalex.org/W2137471483","https://openalex.org/W2138983478","https://openalex.org/W2140369318","https://openalex.org/W2142830692","https://openalex.org/W2144325462","https://openalex.org/W2147663252","https://openalex.org/W2150849997","https://openalex.org/W2154277743","https://openalex.org/W2157665742","https://openalex.org/W2158506982","https://openalex.org/W2165727615","https://openalex.org/W2171882614"],"related_works":["https://openalex.org/W2601983743","https://openalex.org/W3013892292","https://openalex.org/W2028317115","https://openalex.org/W2944912238","https://openalex.org/W1887007488","https://openalex.org/W2752749262","https://openalex.org/W2213547035","https://openalex.org/W2474731057","https://openalex.org/W2909659307","https://openalex.org/W2171882614"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"report":[2],"the":[3,87,124,130,153,204],"cardiovascular":[4],"(CV)":[5],"safety":[6],"profile":[7],"and":[8,64,82,91,111,117,141,170,183,217],"heart":[9],"failure":[10],"(HF)":[11],"risk":[12,103,243,259],"of":[13,19,48,73,86,106,139,147,152,192,244,260],"vildagliptin":[14,66,107,136,236],"from":[15,57],"a":[16,45,256],"large":[17,232],"pool":[18],"studies,":[20],"including":[21],"trials":[22],"in":[23,178,212,262],"high-risk":[24],"patients":[25,154,182,216],"with":[26,35,188,222,240],"type":[27],"2":[28],"diabetes":[29],"mellitus":[30],"(T2DM),":[31],"such":[32],"as":[33],"those":[34],"congestive":[36],"HF":[37,92,208,261],"and/or":[38],"moderate/severe":[39],"renal":[40],"impairment.":[41],"METHODS:":[42],"We":[43],"conducted":[44],"retrospective":[46],"meta-analysis":[47,233],"prospectively":[49],"adjudicated":[50,245],"CV":[51,76,83],"events.":[52,206],"Patient-level":[53],"data":[54],"were":[55,99,201,210],"pooled":[56],"40":[58],"double-blind,":[59],"randomized":[60],"controlled":[61],"phase":[62],"III":[63],"IV":[65],"studies.":[67],"The":[68,102,149],"primary":[69],"endpoint":[70],"was":[71,121,155],"occurrence":[72],"major":[74],"adverse":[75],"events":[77,93,209],"(MACEs;":[78],"myocardial":[79],"infarction,":[80],"stroke":[81],"death).":[84],"Assessments":[85],"individual":[88,205],"MACE":[89,176],"components":[90],"(requiring":[94],"hospitalization":[95],"or":[96],"new":[97],"onset)":[98],"secondary":[100],"endpoints.":[101],"ratio":[104],"(RR)":[105],"(50":[108],"mg":[109],"once-":[110],"twice-daily":[112],"combined)":[113],"versus":[114],"comparators":[115,144],"(placebo":[116],"all":[118],"non-vildagliptin":[119],"treatments)":[120],"calculated":[122],"using":[123],"Mantel-Haenszel":[125],"(M-H)":[126],"method.":[127],"RESULTS:":[128],"Of":[129],"17":[131],"446":[132],"patients,":[133,187,221],"9599":[134],"received":[135,143],"(9251.4":[137],"subject-years":[138,146],"exposure)":[140],"7847":[142],"(7317.0":[145],"exposure).":[148],"mean":[150],"age":[151],"57":[156],"years,":[157],"body":[158],"mass":[159],"index":[160],"30.5":[161],"kg/m(2)":[162],"(nearly":[163],"50%":[164],"obese),":[165],"glycated":[166],"haemoglobin":[167],"concentration":[168],"8.1%":[169],"T2DM":[171],"duration":[172],"5.5":[173],"years.":[174],"A":[175],"occurred":[177],"83":[179],"(0.86%)":[180],"vildagliptin-treated":[181,215,263],"85":[184],"(1.20%)":[185],"comparator-treated":[186,220],"an":[189,223,241],"M-H":[190,224],"RR":[191,225],"0.82":[193],"[95%":[194],"confidence":[195],"interval":[196],"(CI)":[197],"0.61-1.11].":[198],"Similar":[199],"RRs":[200],"observed":[202],"for":[203],"Confirmed":[207],"reported":[211],"41":[213],"(0.43%)":[214],"32":[218],"(0.45%)":[219],"1.08":[226],"(95%":[227],"CI":[228],"0.68-1.70).":[229],"CONCLUSIONS:":[230],"This":[231],"indicates":[234],"that":[235],"is":[237],"not":[238,254],"associated":[239],"increased":[242,258],"MACEs":[246],"relative":[247],"to":[248],"comparators.":[249],"Moreover,":[250],"this":[251],"analysis":[252],"did":[253],"find":[255],"significant":[257],"patients.":[264]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1846464686","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":20},{"year":2017,"cited_by_count":19},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
